Table 2.
Normal (n=6) | High- Cholesterol (n=6) | High- Cholesterol +Thalidomide (n=6) | Normal + Thalidomide (n=6) | |
---|---|---|---|---|
VV Density (n/mm²) | 2.7±0.3 | 6.4±0.7 *,# | 3.5±0.8 | 3.8±0.9 |
VAF (%) | 0.7±0.2 | 1.6±0.2 § | 1.0±0.3 | 1.2±0.2 |
ESF (mm²/mm³) | 43±5 | 104±9 § | 62±18 | 64±13 |
Ratio VV Endothelial Surface/Luminal Endothelial Surface | 24±3% | 61±7% § | 40±12% | 41±7% |
Intima-Media Thickness (mm) | 0.28±0.02 | 0.62±0.09 †,# | 0.35±0.02 | 0.29±0.03 |
Data are presented in Mean±SEM.
VAF=vascular area fraction, ESF=endothelial surface fraction
p<0.01 vs. Normal
p<0.05 vs. High-Cholesterol + Thalidomide
p<0.05 vs. Normal
p ≤ 0.001 vs. Normal and Normal + Thalidomide
p<0.05 vs. all other groups